Zevra Therapeutics (ZVRA) Acquisitions (2022 - 2023)
Zevra Therapeutics (ZVRA) posted Acquisitions of $30.4 million for Q4 2023, up 115.98% on a QoQ basis from $14.1 million in Q3 2022.
Zevra Therapeutics (ZVRA) Acquisitions (2022 - 2023) Analysis & Trends
Zevra Therapeutics' Acquisitions history runs 2 years deep, the most recent figure standing at $30.4 million for Q4 2023.
- Quarterly Acquisitions changed N/A year-over-year to $30.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $44.5 million (up 215.98% YoY) and the FY2023 annual result came in at $30.4 million, up 115.76% from the prior year.
- Acquisitions was $30.4 million for Q4 2023 at Zevra Therapeutics, up from $14.1 million in the prior quarter.
- Across five years, Acquisitions topped out at $30.4 million in Q4 2023 and bottomed at $14.1 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30.40 Mn |
| Sep 30, 2022 | 14.08 Mn |